SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-20-003025
Filing Date
2020-05-13
Accepted
2020-05-12 21:47:08
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 a2241627z424b5.htm 424B5 433717
2 G524037.JPG g524037.jpg GRAPHIC 19886
3 G42085.JPG g42085.jpg GRAPHIC 93598
4 G13042.JPG g13042.jpg GRAPHIC 23881
5 G111729.JPG g111729.jpg GRAPHIC 29586
6 G349687.JPG g349687.jpg GRAPHIC 72668
  Complete submission text file 0001047469-20-003025.txt   765579
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-234414 | Film No.: 20870859
SIC: 2834 Pharmaceutical Preparations